scanX
Dr. Lal Path Labs

Dr. Lal Path Labs

3,032.40
-44.70
(-1.45%)
Market Cap
25,404.09 Cr
EPS
58.48
PE Ratio
52.71
Dividend Yield
0.78 %
52 Week High
3,653.95
52 Week Low
2,293.55
PB Ratio
11.85
Debt to Equity
0.10
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from21 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+61.90 %
+61.90 %
Hold
Hold+14.29 %
+14.29 %
Sell
Sell+23.81 %
+23.81 %

Company News

View All News
Caret
neutral
Dr. Lal PathLabs Schedules Q1 FY26 Earnings Conference Call for July 31, 20254 days ago
Dr. Lal PathLabs Ltd. will host an earnings conference call on July 31, 2025, at 4:30 PM IST to discuss Q1 FY26 financial and operating performance. The call will be led by Executive Chairman (Hony) Brig. Dr. Arvind Lal, CEO Shankha Banerjee, and Group CFO Ved Prakash Goel. The session will begin with management discussion on quarterly results, followed by a Q&A segment for participants. The company operates 298 clinical labs, 6,607 Patient Service Centers, and 12,365 Pick-up Points as of March 31, 2025. In FY25, the diagnostic services provider processed approximately 86 million samples from 28.8 million patients.
neutral
Dr. Lal Path Labs Schedules Quarterly Results Review for July 314 days ago
Dr. Lal Path Labs has announced that it will review its quarterly results on July 31. The diagnostic services company has set this date for examining its financial performance for the quarter.

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Dr. Lal Path Labs
3,032.40
#1 25,404.09
#6 52.71
#1 2,554.80
#8 11.28
#1 492
#2 81.24
61.07
Vijaya Diagnostic Centre
1,141.35
11,720.19
76.40
568.60
20.11
120
22.54
69.41
Metropolis Healthcare
1,965.40
10,181.14
72.90
1,346.30
4.59
146
-20.00
60.15
Thyrocare Technologies
1,246.35
6,604.96
65.32
702.20
20.80
91
60.25
66.39
Krsnaa Diagnostics
850.70
2,746.89
35.58
717.16
25.65
81
10.70
74.83
Suraksha Diagnostic
304.80
1,587.42
50.27
252.09
14.77
31
14.29
35.82
3B BlackBio DX
1,506.50
1,293.04
25.90
96.47
25.47
49
-9.09
47.47
Sastasundar Ventures
296.60
943.50
#1 9.79
1,110.95
35.04
-197
-18.52
55.41
One Global Service Provider
257.10
502.41
27.38
147.04
#1 248.07
18
#1 175.00
52.93
Choksi Laboratories
176.50
122.93
82.21
41.78
6.34
1
28.57
47.41

Automatic Screeners on ScanX

Community
Support 1 Breached
Forecast
Actual
Growth Rate
Revenue Growth
11.28 %
Net Income Growth
35.88 %
Cash Flow Change
6.27 %
ROE
16.08 %
ROCE
4.17 %
EBITDA Margin (Avg.)
4.50 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
175
193
221
210
204
229
269
215
227
257
286
270
276
302
328
305
315
350
380
342
314
277
445
466
445
621
513
509
498
511
543
500
505
555
619
557
564
623
682
622
628
Expenses
128
140
196
119
144
162
182
160
170
184
200
206
203
217
231
227
235
240
257
246
244
218
305
314
309
418
357
388
364
385
390
376
375
395
424
398
401
432
458
443
434
EBITDA
47
53
25
91
60
67
87
55
57
73
86
64
73
84
98
78
80
110
124
96
69
60
140
152
136
203
156
121
133
126
153
124
130
161
196
159
163
191
224
179
195
Operating Profit %
25 %
26 %
9 %
37 %
27 %
27 %
31 %
23 %
23 %
26 %
28 %
22 %
24 %
26 %
27 %
22 %
22 %
28 %
30 %
25 %
19 %
18 %
29 %
31 %
28 %
31 %
28 %
22 %
25 %
23 %
27 %
23 %
24 %
27 %
30 %
26 %
27 %
28 %
31 %
26 %
28 %
Depreciation
8
7
7
7
7
6
7
7
8
7
8
8
11
9
9
10
10
16
18
19
20
18
20
20
20
19
21
31
38
36
39
38
38
35
36
36
37
35
35
36
36
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
5
5
9
12
9
11
9
9
8
8
7
7
6
6
5
5
Profit Before Tax
39
47
18
84
53
61
80
47
49
66
78
56
62
75
88
68
69
89
102
73
45
38
117
129
111
179
131
82
84
81
103
77
83
118
152
116
120
150
183
138
153
Tax
10
16
11
23
18
21
27
16
17
22
27
19
22
26
31
22
22
30
21
19
13
10
30
33
26
46
34
23
21
23
30
23
26
34
42
34
34
42
52
40
-2
Net Profit
29
31
7
61
35
40
53
31
32
44
51
36
40
50
57
46
47
59
81
55
33
28
87
96
85
134
96
58
62
58
72
54
57
84
111
82
86
108
131
98
156
EPS in ₹
5.28
5.61
0.99
7.37
4.17
4.88
6.47
3.78
3.80
5.40
6.19
4.39
4.88
6.00
6.92
5.56
5.72
7.14
9.77
6.56
3.94
3.45
10.34
11.44
10.10
15.87
11.49
6.93
7.41
6.97
8.64
6.37
6.84
9.95
13.16
9.77
10.13
12.79
15.52
11.60
18.57
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
475
625
764
916
1,091
1,374
1,661
2,347
2,386
2,456
2,717
Fixed Assets
150
166
190
208
209
413
447
1,369
1,305
1,228
1,168
Current Assets
282
424
511
623
814
893
1,145
875
973
1,127
1,364
Capital Work in Progress
1
4
18
10
3
11
10
15
5
6
4
Investments
38
64
105
145
185
164
59
66
150
114
327
Other Assets
286
391
452
554
694
786
1,145
898
926
1,109
1,218
Total Liabilities
475
625
764
916
1,091
1,374
1,661
2,347
2,386
2,456
2,717
Current Liabilities
112
91
74
116
138
227
274
500
470
465
402
Non Current Liabilities
20
24
28
8
1
93
111
310
216
105
108
Total Equity
343
510
662
792
951
1,054
1,276
1,537
1,700
1,885
2,207
Reserve & Surplus
260
424
577
734
890
974
1,162
1,418
1,583
1,766
2,089
Share Capital
81
83
83
83
83
83
83
83
83
84
84
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
8
-5
2
37
64
67
48
134
-115
97
-68
Investing Activities
-114
-164
-137
-172
-100
-26
-212
-449
-287
-24
-303
Operating Activities
122
159
171
197
219
284
398
447
456
535
569
Financing Activities
-1
0
-32
13
-55
-190
-139
136
-283
-414
-334
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
55.23 %
55.23 %
55.23 %
55.23 %
55.23 %
55.05 %
55.05 %
55.05 %
55.03 %
55.01 %
54.61 %
54.60 %
54.60 %
54.60 %
53.92 %
53.91 %
53.91 %
53.79 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.00 %
1.83 %
0.00 %
0.00 %
0.00 %
26.15 %
25.42 %
26.82 %
26.82 %
23.91 %
21.68 %
DIIs
6.47 %
5.61 %
4.84 %
5.58 %
5.69 %
5.30 %
5.09 %
6.19 %
6.55 %
7.33 %
7.97 %
8.61 %
9.69 %
12.71 %
12.89 %
13.17 %
16.08 %
17.91 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.70 %
6.24 %
6.93 %
7.45 %
9.03 %
10.44 %
8.24 %
9.03 %
9.50 %
9.31 %
8.37 %
7.26 %
6.47 %
4.91 %
4.10 %
4.01 %
4.11 %
5.23 %
Others
32.60 %
32.92 %
32.99 %
31.74 %
30.05 %
29.22 %
31.63 %
27.73 %
27.09 %
28.35 %
29.05 %
29.53 %
3.09 %
2.35 %
2.27 %
2.10 %
2.00 %
1.38 %
No of Share Holders
68,845
94,123
1,25,953
1,35,068
1,71,846
1,84,508
1,71,602
1,79,636
1,80,163
1,74,444
1,60,679
1,49,901
1,46,741
1,31,189
1,16,606
1,16,236
1,15,699
1,18,656

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 3 4.5 6 12 20 12 12 24 24
Dividend Yield (%) 0.00 0.34 0.43 0.43 0.44 0.77 0.67 0.53 0.97 0.78

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 31 Jul 2025 3,017.00 3,074.55
28 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 28 Jun 2025 2,788.20 2,771.25
06 Jun 2025 DIVIDEND Dividend
₹ 6.00 /share
 06 Jun 2025 2,788.20 2,856.80
25 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 25 Apr 2025 2,714.10 2,788.20
06 Feb 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
 06 Feb 2025 2,792.50 2,792.50
05 Feb 2025 DIVIDEND Dividend
₹ 6.00 /share
 05 Feb 2025 2,759.00 2,829.70
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Jan 2025 2,842.75 2,759.00
05 Nov 2024 DIVIDEND Dividend
₹ 6.00 /share
 05 Nov 2024 3,309.90 3,068.10
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Oct 2024 3,392.30 3,309.90
20 Aug 2024 DIVIDEND Dividend
₹ 6.00 /share
 20 Aug 2024 3,168.45 3,310.20
29 Jun 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 29 Jun 2024 2,231.55 2,779.70
10 Jun 2024 DIVIDEND Dividend
₹ 6.00 /share
 10 Jun 2024 2,231.55 2,797.75
13 Feb 2024 DIVIDEND Dividend
₹ 12.00 /share
 13 Feb 2024 2,517.40 2,458.75
11 Aug 2023 DIVIDEND Dividend
₹ 6.00 /share
 11 Aug 2023 2,483.50 2,364.35
11 Aug 2023 DIVIDEND Dividend
₹ 6.00 /share
 11 Aug 2023 1,949.85 2,364.35
09 Aug 2022 DIVIDEND Dividend
₹ 6.00 /share
 05 Aug 2022 2,170.30 2,415.45
23 Jun 2022 DIVIDEND Dividend
₹ 6.00 /share
 22 Jun 2022 2,206.55 1,972.85
22 Aug 2021 DIVIDEND Dividend
₹ 6.00 /share
 18 Aug 2021 3,732.50 3,852.65
22 Jul 2021 DIVIDEND Dividend
₹ 8.00 /share
 20 Jul 2021 2,854.95 3,372.15
10 Feb 2021 DIVIDEND Dividend
₹ 6.00 /share
 09 Feb 2021 2,245.95 2,408.65

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
Board Meeting Intimation for Declaration Of Financial Results For The Quarter Ended June 30 2025 And Interim Dividend If Any4 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 28, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJun 28, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 05, 2025
Letter Dispatched To The Members Of The Company- Weblink Of The Annual Report FY 2024-25Jun 04, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jun 04, 2025
31St Annual General Meeting To Be Held On June 28 2025Jun 04, 2025
Reg. 34 (1) Annual Report.Jun 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 02, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 30, 2025
Amended Trust DeedMay 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 25, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationApr 25, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 25, 2025
Annual General MeetingApr 25, 2025
Appointment Of Auditors Viz. Internal Auditor Cost Auditor And Secretarial AuditorApr 25, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 25, 2025
Record Date For Final Dividend For The Financial Year Ended March 31 2025Apr 25, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesApr 25, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated April 25 2025Apr 25, 2025
Financial Results For The Quarter And Financial Year Ended March 31 2025Apr 25, 2025
Announcement under Regulation 30 (LODR)-Credit RatingApr 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 21, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 18, 2025
Board Meeting Intimation for Considering And Approving The Audited Financial Results Of The Company For The Quarter And FY Ended March 31 2025 And To Consider Recommending Final Dividend If AnyApr 18, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Grant Of Stock OptionsApr 09, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 31, 2025
Closure of Trading WindowMar 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 20, 2025
Update On Voluntary Liquidation Of Suburban Diagnostics (India) Private Limited (A Wholly Owned Subsidiary Of The Company)Mar 18, 2025
Announcement under Regulation 30 (LODR)-Credit RatingMar 14, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 10, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 07, 2025
Update On Voluntary Liquidation Of Suburban Diagnostics (India) Private Limited Wholly Owned SubsidiaryFeb 06, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 30, 2025

Technical Indicators

RSI(14)
Neutral
67.54
ATR(14)
Volatile
80.88
STOCH(9,6)
Overbought
80.36
STOCH RSI(14)
Overbought
89.59
MACD(12,26)
Bullish
16.64
ADX(14)
Strong Trend
31.11
UO(9)
Bearish
61.88
ROC(12)
Uptrend But Slowing Down
3.83
WillR(14)
Overbought
-19.42
Bearish
5
Neutral
2
Bullish
2

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Aditya Birla Sun Life Flexi Cap Fund Direct-Growth
0.73%
318215
0.37%
0.73%
Sundaram Business Cycle Fund Direct - Growth
1.53%
33931
0.48%
0.44%
Baroda BNP Paribas Small Cap Fund Direct - Growth
1.48%
30000
0.62%
1.48%
Sundaram Large and Mid Cap Fund Direct-Growth
1.30%
30000
0.09%
0.07%
Baroda BNP Paribas Multi Cap Fund Direct-Growth
0.96%
-25000
-0.27%
-0.47%
Tata Business Cycle Fund Direct - Growth
0.68%
17000
0.15%
0.64%
Tata India Pharma & Healthcare Fund Direct-Growth
1.91%
14500
0.25%
0.25%
Shriram Multi Sector Rotation Fund Direct-Growth
0.00%
-12087
-1.73%
0.00%
Bajaj Finserv Healthcare Fund Direct-Growth
2.82%
11566
0.92%
1.53%
HDFC Pharma And Healthcare Fund Direct - Growth
1.81%
6250
0.03%
0.43%
Motilal Oswal Quant Fund Direct-Growth
0.96%
5092
0.96%
0.96%
HDFC Retirement Savings Fund - Hybrid Equity Plan Direct-Growth
0.66%
5000
0.07%
0.66%
HDFC Multi Asset Fund Direct-Growth
0.43%
4783
0.02%
0.10%
UTI Multi Cap Fund Direct-Growth
1.65%
4147
-0.22%
1.65%
Mirae Asset Small Cap Fund Direct-Growth
1.95%
3144
-0.20%
-0.48%
NJ Flexi Cap Fund Direct - Growth
2.03%
2669
-0.05%
-0.09%
NJ Balanced Advantage Fund Direct - Growth
1.45%
-1760
-0.03%
-0.05%
DSP Nifty Smallcap250 Quality 50 Index Fund Direct - Growth
2.09%
1575
-0.03%
-0.24%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.52%
1337
-0.02%
-0.07%
Axis Nifty Smallcap 50 Index Fund Direct-Growth
1.48%
833
-0.10%
-0.21%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.52%
538
-0.02%
-0.07%
NJ ELSS Tax Saver Scheme Direct - Growth
3.99%
453
-0.22%
-0.35%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.20%
414
0.01%
-0.01%
Quantum ESG Best In Class Strategy Fund Direct - Growth
1.43%
364
0.05%
0.17%
Kotak Nifty Smallcap 50 Index Fund Direct - Growth
1.48%
355
-0.10%
-0.21%

About Dr. Lal Path Labs

Dr Lal PathLabs is a leading diagnostic healthcare service provider in India. The company operates a nationwide network of medical laboratory centers, offering over 5000 diagnostic tests and related healthcare services. Its infrastructure includes a National Reference Laboratory in New Delhi, Regional Reference Labs in Kolkata, Bangalore, and Mumbai, 371 clinical laboratories, 5,102 patient service centers, and 10,938 pickup points as of March 31, 2023. The company provides services to individual patients, hospitals, healthcare providers, and corporate customers. Its test catalog includes 481 test panels, 2763 pathology tests, and 1947 radiology and cardiology tests. Dr Lal PathLabs has expanded through acquisitions and has several domestic and international subsidiaries. The company continues to grow its network and enhance its technological capabilities to improve its diagnostic services.
Listing Date
23 Dec, 2015(9 Years, 35 days)
Website
https://www.lalpathlabs.com
Chairperson NameArvind Lal
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Intraday Screeners
Technical Screeners
Candlestick Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104